Modalis Therapeutics (TSE:4883) Total Tax Payable : 円5.23 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Modalis Therapeutics Total Tax Payable?

Modalis Therapeutics's Total Tax Payable for the quarter that ended in Mar. 2024 was 円5.23 Mil.

Modalis Therapeutics's quarterly Total Tax Payable increased from Sep. 2023 (円2.27 Mil) to Dec. 2023 (円5.97 Mil) but then declined from Dec. 2023 (円5.97 Mil) to Mar. 2024 (円5.23 Mil).

Modalis Therapeutics's annual Total Tax Payable declined from Dec. 2021 (円19.28 Mil) to Dec. 2022 (円13.11 Mil) and declined from Dec. 2022 (円13.11 Mil) to Dec. 2023 (円5.97 Mil).

Modalis Therapeutics Total Tax Payable Historical Data

The historical data trend for Modalis Therapeutics's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Modalis Therapeutics Total Tax Payable Chart

Modalis Therapeutics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Tax Payable

Get a 7-Day Free Trial

21.82

21.62

19.28

13.11

5.97

Modalis Therapeutics Quarterly Data
	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Tax Payable	Get a 7-Day Free Trial														21.43	12.77	2.27	5.97	5.23

Modalis Therapeutics Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Modalis Therapeutics Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Modalis Therapeutics's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Modalis Therapeutics (TSE:4883) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Modalis Therapeutics Corp (TSE:4883) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

16-5 Nihombashi-Kabuto-cho, Chuo-ku, Tokyo, JPN, 103-0026

Website

https://www.modalistx.com

Modalis Therapeutics Corp is a drug development company. It is engaged in research and development of Gene Therapy using core platform technology, non-editing CRISPR technology (CRISPR-GNDM). The company's products in pipeline are MDL-201, MDL-202, MDL-204, MDL-205, MDL-206, MDL-101, and MDL-102.

Modalis Therapeutics (TSE:4883) Headlines

No Headlines